Health Technology · Medical Specialties · NSE: AVIENCE · data 2026-10-09

Avience Biomedicals Limited

Health check: Strong (7.2/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹274.5

Market cap

₹152 cr

P/E

12.7

P/B

3.5

ROE

32.4%

ROCE

35.9%

Debt / equity

0.92

Dividend yield

0.00%

1-year return

-30.5%

52-week high

₹414.95

52-week low

₹222

Operating margin

26.1%

Growth

Revenue (last 12 months)	₹53 cr
Net profit (last 12 months)	₹9 cr
Sales growth, 3 years (yearly)	68.8%
Profit growth, 3 years (yearly)	123.6%

Similar companies

Osel Devices Limited (OSELDEVICE) · Nureca Ltd. (NURECA) · Yash Optics and Lens Limited (YASHOPTICS) · Mohini Health & Hygiene Ltd. (MHHL) · Gkb Ophthalmics Limited (GKB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AVIENCE in NSE Scanner →